

IPHARMA CRO: Detailed Company Information & Corporate Profile
Contact top employees from
IPHARMA CRO
Summary
The company currently specializes in the Pharmaceuticals area. The annual revenue of IPHARMA CRO varies between 10M and 50M. To connect with IPHARMA CRO employee register on SignalHire.
| IPHARMA CRO Website | ipharma.ru |
| Industries | |
| IPHARMA CRO Headquarters address | 5, Nobel, territory of the innovation center Skolkovo, Moscow, 121205 RU |
| Company Size | 100-200 employees |
| Specialties | CRO, GCP, Phase 1, Phase 2, Phase 3, Translational, POC, Registration, Viral infections, Russia, Oncology, Endocrinology, Cardiovascular, Autoimmune disease, Psychiatry, Neurology, Bioequivalence, Biosimilars, Therapeutic equivalence, Patient recruitment, Russia and EAEU countries |
| Founded | 2012 |
| Estimated Annual Revenue | $10M - 50M |
Workforce Turnover
Length of Employment
IPHARMA CRO's workforce includes employees across a wide range of tenure levels.
19% have been with the company for 1 to 2 years14% have been with the company for 3 to 4 years19% have been with the company for 5 to 7 years19% have been with the company for 8 to 10 years29% have been with the company for more than 11 yearsContact top employees from
IPHARMA CRO
Companies Similar to IPHARMA CRO
IPHARMA CRO Corporate Information: FAQ
IPHARMA CRO operates in the Pharma industries. More details can be found on the official website: ipharma.ru.
The headquarters of IPHARMA CRO are located in Moscow, Russia.
IPHARMA CRO currently employs 100-200 people.
IPHARMA CRO's revenue is approximately 41.5M.
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.





